Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®
- Conditions
- Interventions
- First Posted Date
- 2013-03-04
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 605
- Registration Number
- NCT01803555
- Locations
- 🇨🇿
Teva Investigational Site 54058, Praha, Czechia
🇫🇷Teva Investigational Site 35090, Nantes, France
🇫🇷Teva Investigational Site 35091, Perpignan, France
First Time Use of SD-809 in Huntington Disease
- First Posted Date
- 2013-02-21
- Last Posted Date
- 2017-09-20
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01795859
- Locations
- 🇺🇸
Teva Investigational Site 032, Atlanta, Georgia, United States
🇺🇸Teva Investigational Site 020, Columbus, Ohio, United States
🇺🇸Teva Investigational Site 057, Birmingham, Alabama, United States
Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)
- Conditions
- Interventions
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2015-06-18
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT01791972
- Locations
- 🇺🇸
Teva Investigational Site 10556, Raleigh, North Carolina, United States
🇺🇸Teva Investigational Site 10555, Denver, Colorado, United States
🇺🇸Teva Investigational Site 10559, Wheaton, Maryland, United States
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
- First Posted Date
- 2013-02-12
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 625
- Registration Number
- NCT01789970
- Locations
- 🇺🇸
Teva Investigational Site 10366, Phoenix, Arizona, United States
🇺🇸Teva Investigational Site 10371, Houston, Texas, United States
🇺🇸Teva Investigational Site 10416, Anniston, Alabama, United States
To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Interventions
- First Posted Date
- 2013-02-07
- Last Posted Date
- 2014-08-11
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT01785433
- Locations
- 🇩🇪
Teva Investigational Site 32169, Gauting, Germany
🇩🇪Teva Investigational Site 32170, Berlin, Germany
🇩🇪Teva Investigational Site 32171, Grosshansdorf, Germany
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
- First Posted Date
- 2013-02-05
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 547
- Registration Number
- NCT01783548
- Locations
- 🇺🇸
Teva Investigational Site 10518, Costa Mesa, California, United States
🇺🇸Teva Investigational Site 10486, Indianapolis, Indiana, United States
🇺🇸Teva Investigational Site 10504, San Diego, California, United States
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
- Conditions
- Interventions
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT01772368
- Locations
- 🇺🇸
Teva Investigational Site 10456, San Antonio, Texas, United States
🇺🇸Teva Investigational Site 10453, Denver, Colorado, United States
🇺🇸Teva Investigational Site 10454, Skillman, New Jersey, United States
A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet
- First Posted Date
- 2013-01-17
- Last Posted Date
- 2013-03-20
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT01769677
- Locations
- 🇺🇸
Teva Investigational Site 10470, Austin, Texas, United States
A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet
- First Posted Date
- 2013-01-01
- Last Posted Date
- 2013-03-20
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT01758978
- Locations
- 🇺🇸
Teva Investigational Site 10471, Austin, Texas, United States
Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2015-06-26
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT01747629
- Locations
- 🇺🇸
Teva Investigational Site 10239, Tallahassee, Florida, United States
🇺🇸Teva Investigational Site 10228, Spartanburg, South Carolina, United States
🇺🇸Teva Investigational Site 10225, Costa Mesa, California, United States